comicbooks.com Join Free
HomeAll-Star Comics › #30
All-Star Comics #30 cover
Cover: Martin Naydel

All-Star Comics #30

Aug 1946 · DC · 0.10 USD
☆ Be the first to review + Add to your collection — Join free
“The Dreams of Madness [Introduction]”

In All-Star Comics #30 (1946), Dr. Mid-Nite stumbles into a surreal realm where germs rule as sovereign beings, and he must confront a reality that twists his sense of self. Written by Gardner Fox and illustrated by Stan Asch, this haunting tale explores identity and perception as Mid-Nite struggles to prove his humanity in a world that insists he’s just another infection. The cover by Martin Naydel captures the eerie, dreamlike tone of a story that lingers long after the final page.

Was this helpful and accurate?
writer Gardner Fox · artist, inker Stan Asch · cover Martin Naydel

This exact issue on

Raw / ungraded $150–$365 2 listings
Verified matches for All-Star Comics #30 · eBay asking prices, seen 8 days ago

Sell my copy

Have this issue — or a whole collection? Get a fair offer from us, skip the marketplace fees and the hassle.

We Buy Collections ▸
Fast, fair offers · we handle grading & shipping

Full credits

artist, inker Stan Asch
cover pencils, inks Martin Naydel

Full plot ⚠ may contain spoilers

▸ Reveal full plot — may contain spoilers

Dr. Mid-Nite finds himself in a world where germs are the lords of creation and he saves a man they plan to save for future study. The humans there convince Mid-Nite that his former life is all a dream, but he uses his scientific ability to try and fight the Germ People. He develops a noxious gas to use on the Germ People, but it fails to work, and he is convinced the other humans are right. But his instinct to fight remains strong and he battles them with his fists until one of the Germ People with the plague enters, blaming it on Mid-Nite. He is then convinced that he is a living sickness.

Plot details indexed by the Grand Comics Database (CC BY-SA).

Key issues in All-Star Comics

Reviews

Reader reviews

No reader reviews yet.